Dexcom beats Q3 earnings forecasts, raises sales guidance
Investor's Business Daily reported that diabetes wearables-maker Dexcom topped third-quarter earnings forecasts on Thursday and reported in-line sales. The report also said Dexcom raised its sales guidance, and that its stock was little moved.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Dexcom beat third-quarter earnings forecasts.
“Diabetes wearables-maker Dexcom topped third-quarter earnings forecasts Thursday”
Investor's Business Daily -
Dexcom reported sales in line with expectations.
“reported in-line sales”
Investor's Business Daily -
Dexcom raised its sales guidance.
“Hikes Sales Guide”
Investor's Business Daily -
Dexcom stock was little moved after the report.
“Dexcom stock was little moved”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-29 20:20 UTC. Labels are computed from the sources, not by the model.